<DOC>
	<DOCNO>NCT01747993</DOCNO>
	<brief_summary>Catheter-associated urinary infection common hospital-acquired infection prevent early catheter removal . This study evaluate tamsulosin reduce failure early catheter removal study elderly woman hospitalize acute condition experience acute urinary retention : 448 woman 75-year old without anatomical neurological cause urinary retention randomize 6 day course tamsulosin 0.4 mg placebo . Catheter removal attempt third dose tamsulosin need replace another catheter within 72 hour define fail attempt .</brief_summary>
	<brief_title>Tamsulosin Urinary Retention Hospitalized Older Women</brief_title>
	<detailed_description>Background : Urinary tract infection frequent hospital-acquired infection . A majority catheter-associated main risk factor duration catheterization . Early removal therefore priority . Treatment alpha-blocker men acute urinary retention due prostatic disease increase rate successful early catheter removal . No intervention study elderly woman urinary retention usually favor acute health issue . However , alpha-blocker prove effective circumstance , prevention acute urinary retention hysterectomy treatment chronic voiding disorder . Objective : To evaluate benefit tamsulosin 6 day old woman hospitalize acute medical condition experience urinary retention . Primary endpoint : Rate fail early catheter removal ( day 3 ) , require placement another catheter within follow 72 hour . Secondary endpoint : rate hospital-acquired urinary tract infection , rate hypotension , length hospitalization . Design : Double-blind multicentric randomize control trial ( tamsulosin 0.4 mg/day placebo orally 6 day ) . Number patient : We assume 40 % failure rate early catheter removal placebo group . Expecting 10 % dropout rate , 448 patient need randomize show reduction rate one third tamsulosin group two-sided alpha level 5 % beta level 20 % . Inclusion criterion : 75-year old woman hospitalize internal medicine geriatric ward bladder catheter le 48 hour acute urinary retention . Non-inclusion criterion : chronic urinary retention ; acute retention anatomical ( pelvic tumor , pelvic surgery ) neurological cause ( peripheral neuropathy , spinal cord compression , multiple sclerosis , amyotrophic lateral sclerosis , Parkinson 's disease ) ; catheter place another indication ( pressure ulcer protection , urine output monitoring ) ; patient end life ; contra-indication alpha-blocker . Course study : The patient receive treatment dose even inclusion ( day 0 ) five follow evening . The catheter remove third dose , midnight noon . The patient follow day 12 . Total time : 36 month ( 35 month inclusion + 12 day participation per patient ) . Number participate center : 8 Expected number inclusion per month center : 2-4</detailed_description>
	<mesh_term>Urinary Retention</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>75year old woman hospitalize internal medicine geriatric ward bladder catheter le 48 hour acute urinary retention . chronic urinary retention ; acute retention anatomical ( pelvic tumor , pelvic surgery ) neurological cause ( peripheral neuropathy , spinal cord compression , multiple sclerosis , amyotrophic lateral sclerosis , Parkinson 's disease ) ; catheter place another indication ( pressure ulcer protection , urine output monitoring ) ; patient end life ; contraindication alphablockers .</criteria>
	<gender>Female</gender>
	<minimum_age>75 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Urinary retention ; urinary catheterization ; alpha block agent ; woman ; elder</keyword>
</DOC>